. 2018 Sep 27;33(6):304–311. doi: 10.1097/YIC.0000000000000236
Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/
Table 2.
Additional efficacy outcomes in the double-blind period (ITT population, MMRM)
